Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 102.98
kr 9268.62kr 102.98
kr 1235.18
60 tablet
Free AirMail shipping Hot
kr 109.85
kr 6590.92kr 109.85
kr 411.61
30 tablet
Free AirMail shipping Hot
kr 116.71
kr 3501.27kr 116.71
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 123.58
kr 11122.41kr 123.58
kr 617.24
60 tablet
Free AirMail shipping Hot
kr 127.01
kr 7620.81kr 127.01
kr 205.63
30 tablet
Free AirMail shipping Hot
kr 130.44
kr 3913.22kr 130.44
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
kr 147.61
kr 13285.17kr 147.61
kr 617.24
60 tablet
Free AirMail shipping Hot
kr 151.04
kr 9062.64kr 151.04
kr 205.63
30 tablet
Free AirMail shipping Hot
kr 154.47
kr 4634.14kr 154.47
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.